Increase of ethanol, meprobamate and pentobarbital metabolism after chronic ethanol administration in man and in rats. 1971

P S Misra, and A Lefévre, and H Ishii, and E Rubin, and C S Lieber

UI MeSH Term Description Entries
D008297 Male Males
D008620 Meprobamate A carbamate with hypnotic, sedative, and some muscle relaxant properties, although in therapeutic doses reduction of anxiety rather than a direct effect may be responsible for muscle relaxation. Meprobamate has been reported to have anticonvulsant actions against petit mal seizures, but not against grand mal seizures (which may be exacerbated). It is used in the treatment of ANXIETY DISORDERS, and also for the short-term management of INSOMNIA but has largely been superseded by the BENZODIAZEPINES. (From Martindale, The Extra Pharmacopoeia, 30th ed, p603) Dapaz,Equanil,Meprospan,Miltown,Méprobamate Richard,Tranmep,Visano
D008862 Microsomes, Liver Closed vesicles of fragmented endoplasmic reticulum created when liver cells or tissue are disrupted by homogenization. They may be smooth or rough. Liver Microsomes,Liver Microsome,Microsome, Liver
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010424 Pentobarbital A short-acting barbiturate that is effective as a sedative and hypnotic (but not as an anti-anxiety) agent and is usually given orally. It is prescribed more frequently for sleep induction than for sedation but, like similar agents, may lose its effectiveness by the second week of continued administration. (From AMA Drug Evaluations Annual, 1994, p236) Mebubarbital,Mebumal,Diabutal,Etaminal,Ethaminal,Nembutal,Pentobarbital Sodium,Pentobarbital, Monosodium Salt,Pentobarbitone,Sagatal,Monosodium Salt Pentobarbital
D002247 Carbon Isotopes Stable carbon atoms that have the same atomic number as the element carbon but differ in atomic weight. C-13 is a stable carbon isotope. Carbon Isotope,Isotope, Carbon,Isotopes, Carbon
D004361 Drug Tolerance Progressive diminution of the susceptibility of a human or animal to the effects of a drug, resulting from its continued administration. It should be differentiated from DRUG RESISTANCE wherein an organism, disease, or tissue fails to respond to the intended effectiveness of a chemical or drug. It should also be differentiated from MAXIMUM TOLERATED DOSE and NO-OBSERVED-ADVERSE-EFFECT LEVEL. Drug Tolerances,Tolerance, Drug,Tolerances, Drug
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

P S Misra, and A Lefévre, and H Ishii, and E Rubin, and C S Lieber
November 1985, Pharmacology, biochemistry, and behavior,
P S Misra, and A Lefévre, and H Ishii, and E Rubin, and C S Lieber
November 1970, The Journal of pharmacology and experimental therapeutics,
P S Misra, and A Lefévre, and H Ishii, and E Rubin, and C S Lieber
January 1988, Alcohol and alcoholism (Oxford, Oxfordshire),
P S Misra, and A Lefévre, and H Ishii, and E Rubin, and C S Lieber
June 1973, Metabolism: clinical and experimental,
P S Misra, and A Lefévre, and H Ishii, and E Rubin, and C S Lieber
January 1978, Annales de la nutrition et de l'alimentation,
P S Misra, and A Lefévre, and H Ishii, and E Rubin, and C S Lieber
January 1997, Addiction biology,
P S Misra, and A Lefévre, and H Ishii, and E Rubin, and C S Lieber
October 1988, Pharmacology, biochemistry, and behavior,
P S Misra, and A Lefévre, and H Ishii, and E Rubin, and C S Lieber
October 1999, Comparative biochemistry and physiology. Part C, Pharmacology, toxicology & endocrinology,
P S Misra, and A Lefévre, and H Ishii, and E Rubin, and C S Lieber
December 1983, Japanese journal of pharmacology,
P S Misra, and A Lefévre, and H Ishii, and E Rubin, and C S Lieber
September 1972, Quarterly journal of studies on alcohol,
Copied contents to your clipboard!